Takashi Kuwayama

6PUBLICATIONS
48CO-AUTHORS
Cancer cell biologyEnvironmental epidemiologyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 23, 2026
Acinic cell carcinoma of the breast in a patient with a BRCA1 pathogenic variant: a case report.

|Jul 08, 2026
Efficacy and safety of eribulin mesylate vs. docetaxel or paclitaxel, combined with trastuzumab and pertuzumab, as first-line treatment for HER2-positive locally advanced or metastatic breast cancer: updated subgroup analyses of JBCRG-M06/EMERALD.

|Apr 16, 2026
Dynamic changes in serum HER2-peptide-specific autoantibodies predict response to neoadjuvant therapy in HER2-positive breast cancer.

|Sep 11, 2024
Retrospective Analysis of the Clinical Usefulness of a Strut-Adjusted Volume Implant in a Single Center.

Arisa Ata-Shiroshita, Takashi Kuwayama, Masako Kato

|Jun 29, 2022
Diagnostic performance of dedicated breast positron emission tomography.

Rikako Hashimoto, Sadako Akashi-Tanaka, Chie Watanabe

|Oct 06, 2018
QOL Evaluation of Nab-Paclitaxel and Docetaxel for Early Breast Cancer.

Hiromi Okuyama, Seigo Nakamura, Sadako Akashi-Tanaka

Pageof 1

Frequent Collaborators

3 joint publications

Seigo Nakamura

3 joint publications

Sadako Akashi-Tanaka

2 joint publications

Terumasa Sawada

2 joint publications

Hiroko Masuda